Harsha Prabhala
Alnylam Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Chronic Lymphocytic Leukemia Research, T-cell and B-cell Immunology, MicroRNA in disease regulation, Immunotherapy and Immune Responses
Most-Cited Works
- → miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis(2010)1,322 cited
- → Elevated IL-17 produced by Th17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma(2010)343 cited
- → An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia(2015)291 cited
- → Anti-Inflammatory Natural Foods(2012)8 cited
- → Expanded Therapeutic Index Of Antithrombin Silencing and Correction Of Aptt In a Hemophilia A Mouse Model(2013)2 cited
- → TH17 Pathway Promotes Tumor Cell Growth and Suppresses Immune Function in Myeloma: Potential for Therapeutic Application(2008)1 cited
- → Multiple Myeloma Cells Express IL-17A Creating An Autocrine Loop: An Attractive Therapeutic Target(2013)
- → Reprogramming Aberrant B Cell-Subsets to Improve Immune Function in Multiple Myeloma(2012)
- Mid1 slternative promoters in B-cell proliferation and systemic lupus erythematosis.(2006)